Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes

Examine red and white blood cells of PNH patients with bone marrow failure syndromes.

Completed

Looking for future studies?

Key information

Conditions

Hemoglobinuria Anemia Anemia, Aplastic Anemia, Hemolytic Bone Marrow Diseases Bone Marrow Failure Disorders Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Hematologic Diseases Hemic and Lymphatic Diseases Hemoglobinuria, Paroxysmal Male Urogenital Diseases Myelodysplastic Syndromes Pathological Conditions, Signs and Symptoms Proteinuria Signs and Symptoms Urination Disorders Urogenital Diseases Urologic Diseases Urological Manifestations

Age range

10 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

At least 10 years of age.
Has aplastic anemia, myelodysplastic syndromes or other bone marrow failure syndromes

Exclusion criteria

Has any condition that might interfere with the patient's participation

Sponsors and collaborators

Lead sponsor

Alexion Pharmaceuticals, Inc.

Industry

Registry information

Official study title

P06-001: (EX)Amination of (P)NH, by (L)Evel (O)f CD59 on (RE)d and White Blood Cells, in Bone Marrow Failure Syndromes

Acronym: EXPLORE

Important dates

Study start: 2010
Primary completion: 2010
Study completion: 2010
First posted: Sep 1, 2010
Registry last updated: Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed